Sandra Levy
ARTICLES BY THIS AUTHOR
- 10/3/2019
Superstars: Pharmacists who went beyond the call of duty
DSN found some of the many pharmacists who do more than asked. Here are their stories. - 10/3/2019
Alembic launches generic Optivar
Alembic's azelastine ophthalmic solution 0.05% is provided as 6mL in a sterile dispensing bottle. - 10/3/2019
Albertsons to switch to recycled prescription bags
Albertsons’ move to recycled prescription bags will save more than 5,000 trees each year, the company said. - 10/3/2019
AmerisourceBergen selected by Karyopharm to support Xpovio
AmerisourceBergen has been chosen by Karyopharm to introduce a new treatment for patients with relapsed or refractory multiple myeloma. - 10/3/2019
NACDS 21st annual Foundation Dinner to feature entertainer Jim Gaffigan
Grammy award-nominated entertainer Jim Gaffigan will headline NACDS Foundation dinner, which is dedicated to improving patient outcomes and public health. - 10/3/2019
Schnucks set to end tobacco sales in January
Beginning Jan. 1, 2020 Schnuck Markets will end all tobacco product sales, and starting Oct. 15 it will offer double Schnucks Rewards points on all OTC smoking cessation products. - 10/3/2019
FDA approves Gilead’s Descovy as PrEP
Descovy is the second FDA approved to prevent HIV infection. - 10/2/2019
Diplomat taps David Skomo as CastiaRx COO
Following the retirement of Chris Luthin, David Skomo has been named COO of Diplomat's pharmacy benefit manager CastiaRx. - 10/2/2019
Perrigo relaunches generic Transderm Scop
Transderm Scop and generics had a market value of roughly $147 million for the 12 months ending August 2019. - 10/2/2019
Hy-Vee suspends sale of Zantac and Topcare brand ranitidine products
Hy-Vee has temporarily stopped selling OTC Zantac and Topcare brand ranitidine products, following an FDA alert that these products contain a probable human carcinogen.
